Predictive oncology and cancer research horizons have partnered to pursue development of cancer drugs

Eagan, minn., march 17, 2023 (globe newswire) -- predictive oncology inc. (nasdaq: poai) together with cancer research horizons, the innovation engine at the core of the world's largest private funder of cancer research, cancer research uk (cruk), today announce that they have partnered to drive the development of oncology drugs utilizing predictive oncology's pedal™ platform.
POAI Ratings Summary
POAI Quant Ranking